This includes a risk SNP for systemic lupus erythematosus (SLE) located in the 3’UTR of IRF5. This SNP reduces the use of a proximal p(A) site, leading to the production of longer and less stable isoforms and consequently to reduced IRF5 levels [25]. This evidence concerns the gene IRF5 and systemic lupus erythematosus.